Ethical issues in the relationship between American physicians and drug companies

作者: Marshall B. Kapp

DOI: 10.3233/JRS-1992-3203

关键词:

摘要:

参考文章(14)
Oscar W Clarke, David Orentlicher, Gifts to Physicians From Industry-Reply JAMA: The Journal of the American Medical Association. ,vol. 266, pp. 2222- 2222 ,(1991) , 10.1001/JAMA.1991.03470160053020
Mary-Margaret Chren, C Seth Landefeld, Thomas H Murray, Doctors, Drug Companies, and Gifts JAMA: The Journal of the American Medical Association. ,vol. 262, pp. 3448- 3451 ,(1989) , 10.1001/JAMA.1989.03430240084035
Peter B. Terry, Pulmonary Physicians, Principles, and Pharmaceuticals Chest. ,vol. 100, pp. 223- 226 ,(1991) , 10.1378/CHEST.100.1.223
Teri Randall, New Guidelines Examine Drug Firm, CME Relations JAMA: The Journal of the American Medical Association. ,vol. 265, pp. 1354- 1354 ,(1991) , 10.1001/JAMA.1991.03460110014003
Marjorie A. Bowman, David L. Pearle, Changes in drug prescribing patterns related to commercial company funding of continuing medical education Journal of Continuing Education in The Health Professions. ,vol. 8, pp. 13- 20 ,(1988) , 10.1002/CHP.4750080104
A. F. Shaughnessy, Drug Promotion in a Family Medicine Training Center JAMA: The Journal of the American Medical Association. ,vol. 260, pp. 926- 926 ,(1988) , 10.1001/JAMA.1988.03410070050025
John K. Iglehart, The Food and Drug Administration and Its Problems New England Journal of Medicine. ,vol. 325, pp. 217- 220 ,(1991) , 10.1056/NEJM199107183250322
MichaelD. Rawlins, DOCTORS AND THE DRUG MAKERS The Lancet. ,vol. 324, pp. 276- 278 ,(1984) , 10.1016/S0140-6736(84)90313-1
C.Richard Conti, John F. Williams, Jeffrey L. Anderson, Harris A. Berman, Rolf M. Gunnar, Gerald P. Herman, Fred W. Lyons, Eugene R. Passamani, Philip R. Reid, Mark E. Silverman, Sylvan Lee Weinberg, Lee Yerkes, Task Force V: The relation of cardiovascular specialists to industry, institutions and organisations Journal of the American College of Cardiology. ,vol. 16, pp. 30- 36 ,(1990) , 10.1016/0735-1097(90)90451-T